W911QY-21-c-0016
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- W911QY-21-C-0016
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W911QY-21-C-0016 Federal contract award
- Awardee
- ELI Lilly And Company
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Indianapolis IN 46285 USA
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground published a Limited/Sole Source Justification Notice on November 25, 2020 for contract W911QY-21-C-0016 awarded on October 27, 2020. This sole source contract procured an undisclosed quantity of LY-CoV-555 monoclonal antibody therapy for the treatment of SARS-CoV-2 from an unknown vendor for an undisclosed amount due to the urgent need to secure supply of this COVID-19 treatment during the pandemic. No other details on pricing terms or period of performance were provided in the redacted justification document.
Notice text
Procurement of LY-CoV-555 monoclonal antibody therapy for the treatment of SARS-CoV-2
Awarded contract W911QY-21-C-0016 to unknown vendor for unknown amount on 2020-10-27.
Files
| File | Type | Posted |
|---|---|---|
| Justification and Approval Other Than Full and Open - Final_Redacted.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity